Mimi and Angela attend 32nd ECCMID in Lisbon

The 32 European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) took place at the end of April 2022 in Lisbon. This was held as a hybrid event and was attended online by Angela and in person by Mimi, who was awarded a travel grant by ECCMID. Mimi presented the results from the P. vivax vaccine efficacy trials in the session ‘Novel observations in protective host responses to infection’.

The congress covered a huge range of topics on infectious diseases and microbiology and was a great opportunity for clinicians to catch up with the latest developments in clinical infectious diseases. Of relevance to the group’s work were a number of lectures on vaccines and malaria. Other particularly interesting talks included keynote lectures by Martin Blaser on ‘Pathogens and the microbiome: antibiotics at the crossroads’ and James Collins on ‘Harnessing deep learning and synthetic biology to fight pathogens’.